Rallybio Corporation

NASDAQ:RLYB

0.5366 (USD) • At close August 29, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q22025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Revenue 0.2120.2120.0380.2990.29900.228000000000000000
Cost of Revenue 000.03-0.0070.0340.0350.0360.0370.0380.03900.0420.0440.0420.0350.0260.0250.0230000
Gross Profit 0.2120.2120.0080.2990.265-0.035-0.036-0.037-0.038-0.0390-0.042-0.044-0.042-0.035-0.026-0.025-0.0230000
Gross Profit Ratio 110.21110.8860-0.158000000000000000
Reseach & Development Expenses 6.0745.7257.3558.2412.91212.90115.88813.28813.1311.20210.79312.1110.1387.6486.0944.966.8189.0377.4955.133.0921.913
General & Administrative Expenses 4.1954.1574.2614.1254.3886.8515.1886.0756.9537.1726.2986.757.4776.676.2195.0213.7123.7872.5921.581.571.931
Selling & Marketing Expenses 0000000000000000000000
SG&A 4.1954.1574.2614.1254.3886.8515.1886.0756.9537.1726.2986.757.4776.676.2195.0213.7123.7872.5921.581.571.931
Other Expenses 000000000.0620.07300.0980.10.1130.109000.0240.0680.05200
Operating Expenses 10.2699.88211.61612.36517.319.75221.07619.36320.08318.37417.09118.8617.61514.31812.3139.98110.5312.82410.0876.714.6623.844
Operating Income -10.057-9.67-11.608-12.066-17.035-19.787-21.112-19.363-20.083-18.374-17.091-18.86-17.615-14.318-12.313-9.981-10.53-12.824-10.087-6.71-4.662-3.844
Operating Income Ratio -47.439-45.613-305.474-40.355-56.9730-92.596000000000000000
Total Other Income Expenses Net 0.3540.2310.5640.60.7990.7580.870.9891.4531.0561.1020.490.370.210.1210.117-0.1290.031-0.430.0810.1040.095
Income Before Tax -9.703-9.439-11.044-11.466-16.236-19.029-20.242-18.374-18.413-16.755-15.989-18.237-17.245-14.108-12.192-9.864-10.659-12.793-10.004-6.629-4.558-3.749
Income Before Tax Ratio -45.769-44.524-290.632-38.348-54.3010-88.781000000000000000
Income Tax Expense 0.2870-0.430000-0.0370.217-1.0950.214-0.4340.06800.1020.437000.00100-0.016
Net Income -9.703-9.439-11.044-11.466-16.236-19.029-20.242-18.374-18.63-15.66-16.203-17.803-17.583-14.401-12.415-10.196-11.127-13.275-10.518-7.155-4.893-3.881
Net Income Ratio -45.769-44.524-290.632-38.348-54.3010-88.781000000000000000
EPS -0.22-0.21-0.25-0.26-0.37-0.47-0.5-0.45-0.46-0.39-0.46-0.58-0.57-0.47-0.42-0.37-0.36-0.6-0.47-0.32-0.22-0.17
EPS Diluted -0.22-0.21-0.25-0.26-0.37-0.47-0.5-0.45-0.46-0.39-0.46-0.58-0.57-0.47-0.42-0.37-0.36-0.6-0.47-0.32-0.22-0.17
EBITDA -10.057-9.642-11.578-12.034-17.001-19.752-21.076-19.326-20.045-18.335-15.95-18.195-17.571-14.066-12.157-9.838-10.634-12.76-9.972-6.601-4.532-3.724
EBITDA Ratio -47.439-45.481-304.684-40.247-56.860-92.439000000000000000